Literature DB >> 9256251

The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells.

A Moilanen1, N Rouleau, T Ikonen, J J Palvimo, O A Jänne.   

Abstract

To assess the importance of various regions of the androgen receptor (AR) in transcriptional regulation, we have compared its activation functions (AFs) in yeast and mammalian cells. The receptor's amino-terminal region contains a major transcriptional activator (AF-1) in both cell types, whereas AF-2 in the ligand-binding domain (LBD) is very weak in mammalian cells but clearly functional in the yeast. Hormone-binding ability of LBD is mandatory for AF-2 to operate, as illustrated by mutated LBD constructs. The activity of AF-2 in yeast is severely attenuated when the hinge region is attached to LBD, suggesting that the former region modulates AF-2 in vivo, probably by presenting an interface for interacting proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256251     DOI: 10.1016/s0014-5793(97)00791-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

2.  The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.

Authors:  P Alen; F Claessens; G Verhoeven; W Rombauts; B Peeters
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Nuclear compartmentalization of N-CoR and its interactions with steroid receptors.

Authors:  Yin Wu; Hisaya Kawate; Keizo Ohnaka; Hajime Nawata; Ryoichi Takayanagi
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Intrinsic biocontainment: multiplex genome safeguards combine transcriptional and recombinational control of essential yeast genes.

Authors:  Yizhi Cai; Neta Agmon; Woo Jin Choi; Alba Ubide; Giovanni Stracquadanio; Katrina Caravelli; Haiping Hao; Joel S Bader; Jef D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

5.  Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.

Authors:  Grant Buchanan; Eleanor F Need; Jeffrey M Barrett; Tina Bianco-Miotto; Vanessa C Thompson; Lisa M Butler; Villis R Marshall; Wayne D Tilley; Gerhard A Coetzee
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

6.  The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.

Authors:  C L Bevan; S Hoare; F Claessens; D M Heery; M G Parker
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.

Authors:  A M Moilanen; H Poukka; U Karvonen; M Häkli; O A Jänne; J J Palvimo
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription.

Authors:  Nathalie Rouleau; Andrii Domans'kyi; Mati Reeben; Anu-Maarit Moilanen; Kristina Havas; Zhigang Kang; Tom Owen-Hughes; Jorma J Palvimo; Olli A Jänne
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

10.  SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.

Authors:  Sanna Kaikkonen; Tiina Jääskeläinen; Ulla Karvonen; Miia M Rytinki; Harri Makkonen; Daniel Gioeli; Bryce M Paschal; Jorma J Palvimo
Journal:  Mol Endocrinol       Date:  2008-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.